Coronary risk factors 6-12 months after coronary artery bypass grafting. Comparison of surveys in 1986, 1990 and 1994

Med J Aust. 1994 Nov 7;161(9):536-7.

Abstract

Objective: To assess coronary risk factors and management 6-12 months after coronary artery bypass grafting.

Design: Patient survey by questionnaire after discharge from hospital in 1994 and comparison with similar surveys from 1990 and 1986.

Setting and patients: One hundred and ninety-four patients undergoing coronary artery bypass grafting at one hospital campus between 1 March 1993 and 31 August 1993. Replies to questionnaires were received from 175 patients (90%); we had clinical and biochemical data for 166-175 patients (86%-90%).

Results: The proportion with hypercholesterolaemia (serum cholesterol levels > or = 6.5 mmol/L) declined from 60% in 1986 to 9% in 1994. Those with diastolic hypertension (> or = 95 mmHg) declined from 23% to 3%. The proportion of current smokers remained low at 6%. The proportion overweight had increased from 32% in 1986 to 47% in 1994. The proportion taking lipid-regulating drugs increased from 2% in 1986 to 37% in 1994.

Conclusion: Coronary risk factors after coronary artery bypass grafting appear to be better managed in 1994 than in earlier years, but there may still be a need for improvement in lipid disorders and weight.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antihypertensive Agents / therapeutic use
  • Cholesterol / blood
  • Coronary Artery Bypass / statistics & numerical data*
  • Coronary Disease / epidemiology*
  • Coronary Disease / prevention & control
  • Female
  • Humans
  • Hypercholesterolemia / epidemiology
  • Hypercholesterolemia / prevention & control
  • Hypertension / epidemiology
  • Hypertension / prevention & control
  • Hypolipidemic Agents / therapeutic use
  • Male
  • Middle Aged
  • New South Wales / epidemiology
  • Obesity / epidemiology
  • Obesity / prevention & control
  • Risk Factors
  • Smoking / epidemiology
  • Smoking Prevention

Substances

  • Antihypertensive Agents
  • Hypolipidemic Agents
  • Cholesterol